Literature DB >> 20435320

Neuronal NOS is dislocated during muscle atrophy in amyotrophic lateral sclerosis.

Naoki Suzuki1, Hideki Mizuno, Hitoshi Warita, Shin'ichi Takeda, Yasuto Itoyama, Masashi Aoki.   

Abstract

Previously, we demonstrated that neuronal nitric oxide synthase (nNOS) is activated and promotes muscle atrophy in skeletal muscle during tail suspension, a model of unloading and denervation. Here, we examined patients with amyotrophic lateral sclerosis (ALS) and mutant (H46R) SOD1 transgenic (Tg) mice model using immunohistochemistry, Western blotting and real time PCR. We found cytoplasmic nNOS staining of angulated muscle fibers in patients with ALS. We also examined mutant SOD1 Tg mice and found cytoplasmic nNOS staining even before the onset of clinical muscle atrophy. In the Tg mice, nNOS was largely extracted with 100 mM NaCl and barely detected in the pellet fraction, suggesting fragile anchoring of nNOS to the sarcolemma. We also showed an elevated expression of atrogin-1, key molecules in muscle atrophy at the end stage. A common nNOS dislocation/atrogin-1/muscle atrophy pathway among tail suspension, denervation and ALS is suggested. nNOS modulation therapy may be beneficial in several types of muscle atrophy. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20435320     DOI: 10.1016/j.jns.2010.03.022

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  16 in total

Review 1.  The Sick and the Weak: Neuropathies/Myopathies in the Critically Ill.

Authors:  O Friedrich; M B Reid; G Van den Berghe; I Vanhorebeek; G Hermans; M M Rich; L Larsson
Journal:  Physiol Rev       Date:  2015-07       Impact factor: 37.312

2.  Loss of sarcolemmal nNOS is common in acquired and inherited neuromuscular disorders.

Authors:  E L Finanger Hedderick; J L Simmers; A Soleimani; E Andres-Mateos; R Marx; D C Files; L King; T O Crawford; A M Corse; R D Cohn
Journal:  Neurology       Date:  2011-03-15       Impact factor: 9.910

3.  Altered expression and splicing of Ca(2+) metabolism genes in myotonic dystrophies DM1 and DM2.

Authors:  A Vihola; M Sirito; L L Bachinski; O Raheem; M Screen; T Suominen; R Krahe; B Udd
Journal:  Neuropathol Appl Neurobiol       Date:  2013-06       Impact factor: 8.090

4.  Sarcolemmal targeting of nNOSμ improves contractile function of mdx muscle.

Authors:  Daniela L Rebolledo; Min Jeong Kim; Nicholas P Whitehead; Marvin E Adams; Stanley C Froehner
Journal:  Hum Mol Genet       Date:  2015-11-24       Impact factor: 6.150

Review 5.  Immunological cells and functions in Gaucher disease.

Authors:  Manoj Kumar Pandey; Gregory A Grabowski
Journal:  Crit Rev Oncog       Date:  2013

Review 6.  Nitric oxide in myogenesis and therapeutic muscle repair.

Authors:  Clara De Palma; Emilio Clementi
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

7.  Molecular and cellular mechanisms of skeletal muscle atrophy: an update.

Authors:  Alessandro Fanzani; Viviane M Conraads; Fabio Penna; Wim Martinet
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-06-07       Impact factor: 12.910

8.  Mechanisms underlying ICU muscle wasting and effects of passive mechanical loading.

Authors:  Monica Llano-Diez; Guillaume Renaud; Magnus Andersson; Humberto Gonzales Marrero; Nicola Cacciani; Henrik Engquist; Rebeca Corpeño; Konstantin Artemenko; Jonas Bergquist; Lars Larsson
Journal:  Crit Care       Date:  2012-10-26       Impact factor: 9.097

9.  Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS.

Authors:  Sarina Meinen; Shuo Lin; Markus A Rüegg; Anna Rostedt Punga
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

10.  A Hypothesis for Examining Skeletal Muscle Biopsy-Derived Sarcolemmal nNOSμ as Surrogate for Enteric nNOSα Function.

Authors:  Arun Chaudhury
Journal:  Front Med (Lausanne)       Date:  2015-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.